Home > Quotes > RDY > Press Releases

Dr. Reddy's Laboratories Ltd Press Releases

RDY 
$37.52
*  
0.20
  negative  
0.54%
Get RDY Alerts
*Delayed - data as of May 24, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Dr. Reddy’s Q4 & FY13 Financial Results
05/14/2013 6:08AM - Business Wire

Dr. Reddy's to Release Q4 and Full Year FY13 Results on May 14, 2013
04/30/2013 12:20AM - Business Wire

Dr. Reddy’s Announces the Relocation of Their North America Headquarters and Establishment of a R&D Center in Princeton, NJ, USA
04/09/2013 10:09AM - Business Wire

Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection
04/04/2013 1:55AM - Business Wire

Dr. Reddy’s Appoints GV Prasad as Chairman and Satish Reddy as Vice-Chairman of the Company
04/01/2013 7:32AM - Business Wire

Dr. Reddy’s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP)
03/29/2013 6:45AM - Business Wire

Dr. Reddy’s and Nordion Inc. (formerly MDS Inc.) Settle Claims
03/22/2013 11:37AM - Business Wire

Dr. Reddy’s Laboratories Announces Dr. K. Anji Reddy Has Passed Away
03/15/2013 11:12AM - Business Wire

Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection
03/05/2013 12:19AM - Business Wire

Dr. Reddy’s Holds 98.6% of the Shares in OctoPlus after the Post Closing Acceptance Period
02/28/2013 1:40AM - Business Wire